Table 3.
The area of NSFT and LPO level between patients and healthy controls (x ± s)
| Area of NSFT | time | patients | controls | t | P |
|---|---|---|---|---|---|
| Concentration 1 | 5 min | 1131.73 ± 514.22 | 1584.29 ± 437.71 | -2.55a | 0.013* |
| 10 min | 3378.83 ± 1089.75 | 4070.81 ± 822.53 | -3.20a | 0.002* | |
| Concentration 2 | 5 min | 929.39 ± 485.68 | 1172.17 ± 459.58 | -2.29a | 0.024* |
| 10 min | 2734.20 ± 1169.64 | 3317.38 ± 817.92 | -2.58a | 0.012* | |
| Concentration 3 | 5 min | 638.97 ± 438.91 | 933.86 ± 483.69 | -2.86a | 0.06 |
| 10 min | 2068.58 ± 1077.85 | 2759.60 ± 970.91 | -3.01a | 0.003* | |
| LPO(umol/L) | - | 8.159 ± 2.191 | 4.582 ± 2.373 | 7.004 | <0.001** |
NSFT, niacin skin flush test
a: Student’s t-test
*P<0.05;**P<0.001